Video Credit: Wochit News - Duration: 00:33s - Published
Kidney Damage Caused By COVID-19
22 (UPI) -- COVID-19 causes acute kidney injury that can lead to death in some people infected with the virus, a study published Tuesday by the Clinical Journal of the American Society of Nephrology found.
In an analysis of nearly 1,400 patients with the new coronavirus in Wuhan, where the pandemic began, 7% of those who required hospital care developed acute kidney injury, the data showed.
Advertisement Of those who experienced this complication, 72% died of COVID-19, the researchers said.
Among those without kidney damage, 10% died from the virus.
As the pandemic grinds on and the holidays loom, many people may be wishing they could get their brains working better. Fortunately, a new, double-blind study finds having a nice, hot cup of cocoa is not only good for the soul--it's also good for the brain. UPI reports British and American researchers say flavanol-rich cocoa drinks can improve brain oxygenation and cognitive performance in healthy adults. Flavanols are small molecules found in many fruits and vegetables, and cocoa, too.
The CDC is urging Americans not to travel for the Thanksgiving holidays. The move to limit travel is in an effort to limit the spread of COVID-19. According to UPI, a "strong recommendation" was made as the agency published updated guidelines for holiday travel. The federal agency also issued guidance on gatherings during the holidays. The agency said the need for caution is in response to the "surge in new cases, hospitalizations and deaths".
People who have recovered from COVID-19 are safe from reinfection with the virus for at least six months. The data is according to a study posted online Friday by researchers at Oxford University in England. To date, studies have found that antibodies against the new coronavirus offer varying levels of immunity from infection. According to UPI, some researchers have found that immunity may be only 90 days in some people.
A new study reveals a COVID-19 vaccine under development in England safely promotes an immune response against the virus. According to UPI, the vaccine is in Phase 2 of clinical trials with Astra Zeneca, and is particularly effective in elderly recipients who are over age 70. Researchers say the finding of the 'robust' responses in older people in their study is both significant and encouraging.
The novel coronavirus pandemic is having an enormous impact on the mental health of America's senior citizens. Now, a nationwide survey reveals more than 60% of seniors with depression in the United States won't seek treatment for their condition. UPI reports genetic testing company Myriad Neuroscience says one-third of 1500 adults 65 and older surveyed believe they can 'snap out' of it on their own.
Over one million people have now died from coronavirus worldwide. This milestone comes almost nine months after the first Covid-19 death was recorded in Wuhan, China. Data captured by Johns Hopkins University shows that the USA, Brazil and India make up for nearly half the global coronavirus deaths. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
A method for fast, cheap, yet accurate testing for COVID-19 infection has been developed by a team of researchers. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics. This makes the method particularly attractive for places and situations with limited resources. It is equally interesting for repeated testing and for moving resources from expensive diagnostics to other parts of the care chain. The study led by researchers at the Karolinska Institutet was published in the journal Nature Communications."We started working on the issue of developing a readily available testing method as soon as we saw the developments in Asia and southern Europe, and before the situation reached crisis point in Sweden," says principal investigator Bjorn Reinius, research leader at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet. "Our method was effectively finished already by the end of April, and we then made all the data freely available online."The spread of the new coronavirus at the end of 2019 in China's Wuhan region quickly escalated into a global pandemic. The relatively high transmission rate and a large number of asymptomatic infections led to a huge, worldwide need for fast, affordable, and effective diagnostic tests that could be performed in clinical as well as non-clinical settings.